Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Am J Transplant ; 16(3): 833-40, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26663441

ABSTRACT

The authors previously identified plasma plasminogen activator inhibitor-1 (PAI-1) level as a quantitative lung injury biomarker in primary graft dysfunction (PGD). They hypothesized that plasma levels of PAI-1 used as a quantitative trait could facilitate discovery of genetic loci important in PGD pathogenesis. A two-stage cohort study was performed. In stage 1, they tested associations of loci with PAI-1 plasma level using linear modeling. Genotyping was performed using the Illumina CVD Bead Chip v2. Loci meeting a p < 5 × 10(-4) cutoff were carried forward and tested in stage 2 for association with PGD. Two hundred ninety-seven enrollees were evaluated in stage 1. Six loci, associated with PAI-1, were carried forward to stage 2 and evaluated in 728 patients. rs3168046 (Toll interacting protein [TOLLIP]) was significantly associated with PGD (p = 0.006). The increased risk of PGD for carrying at least one copy of this variant was 11.7% (95% confidence interval 4.9-18.5%). The false-positive rate for individuals with this genotype who did not have PGD was 6.1%. Variants in the TOLLIP gene are associated with higher circulating PAI-1 plasma levels and validate for association with clinical PGD. A protein quantitative trait analysis for PGD risk prioritizes genetic variations in TOLLIP and supports a role for Toll-like receptors in PGD pathogenesis.


Subject(s)
Biomarkers/analysis , Genetic Variation/genetics , Intracellular Signaling Peptides and Proteins/genetics , Lung Transplantation/adverse effects , Primary Graft Dysfunction/diagnosis , Quantitative Trait Loci , Adult , Female , Follow-Up Studies , Genotype , Humans , Male , Middle Aged , Phenotype , Plasminogen Activator Inhibitor 1/blood , Primary Graft Dysfunction/blood , Primary Graft Dysfunction/etiology , Prognosis , Prospective Studies
2.
Am J Transplant ; 15(8): 2188-96, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25877792

ABSTRACT

Primary graft dysfunction (PGD) is a major cause of early mortality after lung transplant. We aimed to define objective estimates of PGD risk based on readily available clinical variables, using a prospective study of 11 centers in the Lung Transplant Outcomes Group (LTOG). Derivation included 1255 subjects from 2002 to 2010; with separate validation in 382 subjects accrued from 2011 to 2012. We used logistic regression to identify predictors of grade 3 PGD at 48/72 h, and decision curve methods to assess impact on clinical decisions. 211/1255 subjects in the derivation and 56/382 subjects in the validation developed PGD. We developed three prediction models, where low-risk recipients had a normal BMI (18.5-25 kg/m(2) ), chronic obstructive pulmonary disease/cystic fibrosis, and absent or mild pulmonary hypertension (mPAP<40 mmHg). All others were considered higher-risk. Low-risk recipients had a predicted PGD risk of 4-7%, and high-risk a predicted PGD risk of 15-18%. Adding a donor-smoking lung to a higher-risk recipient significantly increased PGD risk, although risk did not change in low-risk recipients. Validation demonstrated that probability estimates were generally accurate and that models worked best at baseline PGD incidences between 5% and 25%. We conclude that valid estimates of PGD risk can be produced using readily available clinical variables.


Subject(s)
Lung Transplantation , Primary Graft Dysfunction , Adult , Female , Humans , Male , Risk Factors
3.
Am J Transplant ; 14(9): 2081-7, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24984921

ABSTRACT

Since 2006, waitlist candidates with portopulmonary hypertension (POPH) have been eligible for standardized Model for End-Stage Liver Disease (MELD) exception points. However, there are no data evaluating the current POPH exception policy and its implementation. We used Organ Procurement and Transplantation Network (OPTN) data to compare outcomes of patients with approved POPH MELD exceptions from 2006 to 2012 to all nonexception waitlist candidates during this period. Since 2006, 155 waitlist candidates had approved POPH MELD exceptions, with only 73 (47.1%) meeting the formal OPTN exception criteria. Furthermore, over one-third of those with approved POPH exceptions either did not fulfill hemodynamic criteria consistent with POPH or had missing data, with 80% of such patients receiving a transplant based on receiving exception points. In multivariable multistate survival models, waitlist candidates with POPH MELD exceptions had an increased risk of death compared to nonexception waitlist candidates, regardless of whether they did (hazard ratio [HR]: 2.46, 95% confidence interval [CI]: 1.73-3.52; n = 100) or did not (HR: 1.60, 95% CI: 1.04-2.47; n = 55) have hemodynamic criteria consistent with POPH. These data highlight the need for OPTN/UNOS to reconsider not only the policy for POPH MELD exceptions, but also the process by which such points are awarded.


Subject(s)
Health Policy , Hypertension, Pulmonary/complications , Liver Transplantation , Female , Humans , Hypertension, Pulmonary/surgery , Male , Middle Aged , Treatment Outcome , Waiting Lists
4.
Am J Transplant ; 14(2): 446-52, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24400993

ABSTRACT

Inherent recipient factors, including pretransplant diagnosis, obesity and elevated pulmonary pressures, are established primary graft dysfunction (PGD) risks. We evaluated the relationship between preoperative lung injury biomarkers and PGD to gain further mechanistic insight in recipients. We performed a prospective cohort study of recipients in the Lung Transplant Outcomes Group enrolled between 2002 and 2010. Our primary outcome was Grade 3 PGD on Day 2 or 3. We measured preoperative plasma levels of five biomarkers (CC-16, sRAGE, ICAM-1, IL-8 and Protein C) that were previously associated with PGD when measured at the postoperative time point. We used multivariable logistic regression to adjust for potential confounders. Of 714 subjects, 130 (18%) developed PGD. Median CC-16 levels were elevated in subjects with PGD (10.1 vs. 6.0, p<0.001). CC-16 was associated with PGD in nonidiopathic pulmonary fibrosis (non-IPF) subjects (OR for highest quartile of CC-16: 2.87, 95% CI: 1.37, 6.00, p=0.005) but not in subjects with IPF (OR 1.38, 95% CI: 0.43, 4.45, p=0.59). After adjustment, preoperative CC-16 levels remained associated with PGD (OR: 3.03, 95% CI: 1.26, 7.30, p=0.013) in non-IPF subjects. Our study suggests the importance of preexisting airway epithelial injury in PGD. Markers of airway epithelial injury may be helpful in pretransplant risk stratification in specific recipients.


Subject(s)
Biomarkers/blood , Lung Diseases/surgery , Lung Transplantation/adverse effects , Primary Graft Dysfunction/diagnosis , Uteroglobin/blood , Adult , Aged , Female , Follow-Up Studies , Humans , Lung Diseases/blood , Male , Middle Aged , Preoperative Care , Primary Graft Dysfunction/blood , Primary Graft Dysfunction/etiology , Prognosis , Prospective Studies
5.
Am J Transplant ; 13(3): 754-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23331756

ABSTRACT

Early epithelial injury after lung transplantation may contribute to development of bronchiolitis obliterans syndrome (BOS). We evaluated the relationship between early postoperative soluble receptor for advanced glycation end-product (sRAGE) levels, a marker of type I alveolar cell injury and BOS. We performed a cohort study of 106 lung transplant recipients between 2002 and 2006 at the University of Pennsylvania with follow-up through 2010. Plasma sRAGE was measured 6 and 24 h after transplantation. Cox proportional hazards models were used to evaluate the association between sRAGE and time to BOS, defined according to ISHLT guidelines. Sixty (57%) subjects developed BOS. The average time to BOS was 3.4 years. sRAGE levels measured at 6 h (HR per SD of sRAGE: 1.69, 95% CI: 1.11, 2.57, p = 0.02) and 24 h (HR per SD of sRAGE: 1.74, 95% CI: 1.14, 2.65, p = 0.01) were associated with an increased hazard of BOS. Multivariable Cox regression indicated this relationship was independent of potential confounders. Elevated plasma sRAGE levels measured in the immediate postoperative period are associated with the development of BOS. Early epithelial injury after transplantation may contribute to the development of fibrosis in BOS.


Subject(s)
Biomarkers/blood , Bronchiolitis Obliterans/diagnosis , Graft Rejection/diagnosis , Lung Transplantation/adverse effects , Postoperative Complications , Receptors, Immunologic/blood , Adult , Bronchiolitis Obliterans/blood , Female , Follow-Up Studies , Graft Rejection/blood , Graft Rejection/etiology , Humans , Male , Middle Aged , Prognosis , Receptor for Advanced Glycation End Products , Retrospective Studies , Risk Factors , Syndrome
6.
Eur Respir J ; 39(2): 359-65, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21885386

ABSTRACT

The supplemental oxygen flow rate is a common bedside measure of gas exchange impairment. We aimed to determine whether a titrated oxygen requirement (TOR) predicted mortality in idiopathic pulmonary fibrosis (IPF). We examined 104 adults with IPF enrolled in a prospective cohort study and a validation cohort of 151 adults with a variety of interstitial lung diseases (ILDs). The TOR was defined as the lowest oxygen flow rate required to maintain an oxyhaemoglobin saturation of 96% while standing. Cox proportional hazards models and time-dependent receiver operating characteristic curves were used to examine survival time. A higher TOR was associated with a greater mortality rate independent of forced vital capacity and 6-min walk test results in IPF (adjusted hazard ratio (per 1 L·min(-1)) 1.16, 95% CI 1.06-1.27). The TOR was at least as accurate as pulmonary function and 6-min walk testing at predicting 1-yr mortality. Findings were similar in other ILDs. The TOR is a simple, inexpensive bedside measurement that aids prognostication in IPF.


Subject(s)
Idiopathic Pulmonary Fibrosis/mortality , Idiopathic Pulmonary Fibrosis/therapy , Oxygen Inhalation Therapy/mortality , Oxygen Inhalation Therapy/methods , Severity of Illness Index , Aged , Female , Humans , Idiopathic Pulmonary Fibrosis/physiopathology , Lung Diseases, Interstitial/mortality , Lung Diseases, Interstitial/physiopathology , Lung Diseases, Interstitial/therapy , Male , Middle Aged , Oxygen Inhalation Therapy/standards , Physical Endurance/physiology , Predictive Value of Tests , Prognosis , Prospective Studies , Pulmonary Gas Exchange/physiology , Reproducibility of Results , Risk Factors , Treatment Outcome , Vital Capacity/physiology , Walking
7.
Eur Respir J ; 39(4): 846-54, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22034646

ABSTRACT

Airflow obstruction is an independent risk factor for cardiovascular events in the general population. The affected vascular bed and contribution of emphysema to cardiovascular risk are unclear. We examined whether an obstructive pattern of spirometry and quantitatively defined emphysema were associated with subclinical atherosclerosis in the carotid, peripheral and coronary circulations. The Multi-Ethnic Study of Atherosclerosis recruited participants aged 45-84 yrs without clinical cardiovascular disease. Spirometry, carotid intima-media thickness (IMT), ankle-brachial index (ABI) and coronary artery calcium (CAC) were measured using standard protocols. Percentage of emphysema-like lung was measured in the lung windows of cardiac computed tomography scans among 3,642 participants. Multiple linear regression was used to adjust for cardiac risk factors, including C-reactive protein. Decrements in forced expiratory volume in 1 s (FEV(1)) and FEV(1)/forced vital capacity ratio were associated with greater internal carotid IMT, particularly among smokers (p=0.03 and p<0.001, respectively) whereas percentage emphysema was associated with reduced ABI regardless of smoking history (p=0.004). CAC was associated with neither lung function (prevalence ratio for the presence of CAC in severe airflow obstruction 0.99, 95% CI 0.91-1.07) nor percentage emphysema. An obstructive pattern of spirometry and emphysema were associated distinctly and independently with subclinical atherosclerosis in the carotid arteries and peripheral circulation, respectively, and were not independently related to CAC.


Subject(s)
Airway Obstruction/epidemiology , Coronary Artery Disease/epidemiology , Emphysema/epidemiology , Pulmonary Disease, Chronic Obstructive/epidemiology , Aged , Aged, 80 and over , Airway Obstruction/diagnosis , Ankle Brachial Index/statistics & numerical data , Calcinosis/diagnosis , Calcinosis/epidemiology , Carotid Artery Diseases/diagnosis , Carotid Artery Diseases/epidemiology , Carotid Intima-Media Thickness/statistics & numerical data , Coronary Artery Disease/diagnosis , Emphysema/diagnosis , Female , Humans , Male , Middle Aged , Prevalence , Pulmonary Disease, Chronic Obstructive/diagnosis , Risk Factors , Severity of Illness Index , Spirometry/statistics & numerical data , United States/epidemiology
8.
Am J Transplant ; 11(11): 2517-22, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21883907

ABSTRACT

Primary graft dysfunction (PGD) after lung transplantation may result from ischemia reperfusion injury (IRI). The innate immune response to IRI may be mediated by Toll-like receptor and IL-1-induced long pentraxin-3 (PTX3) release. We hypothesized that elevated PTX3 levels were associated with PGD. We performed a nested case control study of lung transplant recipients with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) from the Lung Transplant Outcomes Group cohort. PTX3 levels were measured pretransplant, and 6 and 24 h postreperfusion. Cases were subjects with grade 3 PGD within 72 h of transplantation and controls were those without grade 3 PGD. Generalized estimating equations and multivariable logistic regression were used for analysis. We selected 40 PGD cases and 79 non-PGD controls. Plasma PTX3 level was associated with PGD in IPF but not COPD recipients (p for interaction < 0.03). Among patients with IPF, PTX3 levels at 6 and 24 h were associated with PGD (OR = 1.6, p = 0.02 at 6 h; OR = 1.4, p = 0.008 at 24 h). Elevated PTX3 levels were associated with the development of PGD after lung transplantation in IPF patients. Future studies evaluating the role of innate immune activation in IPF and PGD are warranted.


Subject(s)
C-Reactive Protein/metabolism , Idiopathic Pulmonary Fibrosis/surgery , Lung Transplantation/physiology , Primary Graft Dysfunction/etiology , Reperfusion Injury/complications , Serum Amyloid P-Component/metabolism , Adult , Case-Control Studies , Female , Humans , Idiopathic Pulmonary Fibrosis/physiopathology , Immunity, Innate , Lung Transplantation/adverse effects , Male , Middle Aged , Primary Graft Dysfunction/blood , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/surgery , Reperfusion Injury/immunology
9.
Am J Transplant ; 11(3): 561-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21299834

ABSTRACT

Primary graft dysfunction (PGD) is the leading cause of early posttransplant morbidity and mortality after lung transplantation. Clara cell secretory protein (CC16) is produced by the nonciliated lung epithelium and may serve as a plasma marker of epithelial cell injury. We hypothesized that elevated levels of CC16 would be associated with increased odds of PGD. We performed a prospective cohort study of 104 lung transplant recipients. Median plasma CC16 levels were determined at three time points: pretransplant and 6 and 24 h posttransplant. The primary outcome was the development of grade 3 PGD within the first 72 h after transplantation. Multivariable logistic regression was performed to evaluate for confounding by donor and recipient demographics and surgical characteristics. Twenty-nine patients (28%) developed grade 3 PGD within the first 72 h. The median CC16 level 6 h after transplant was significantly higher in patients with PGD [13.8 ng/mL (IQR 7.9, 30.4 ng/mL)] than in patients without PGD [8.2 ng/mL (IQR 4.5, 19.1 ng/mL)], p = 0.02. Elevated CC16 levels were associated with increased odds of PGD after lung transplantation. Damage to airway epithelium or altered alveolar permeability as a result of lung ischemia and reperfusion may explain this association.


Subject(s)
Biomarkers/blood , Lung Transplantation/adverse effects , Primary Graft Dysfunction/blood , Primary Graft Dysfunction/diagnosis , Uteroglobin/blood , Adult , Cohort Studies , Female , Humans , Male , Middle Aged , Prognosis , Prospective Studies
10.
Am J Transplant ; 9(2): 389-96, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19120076

ABSTRACT

Primary graft dysfunction (PGD) after lung transplantation causes significant morbidity and mortality. We aimed to determine the role of cytokines and chemokines in PGD. This is a multicenter case-control study of PGD in humans. A Luminex analysis was performed to determine plasma levels of 25 chemokines and cytokines before and at 6, 24, 48 and 72 h following allograft reperfusion in 25 cases (grade 3 PGD) and 25 controls (grade 0 PGD). Biomarker profiles were evaluated using a multivariable logistic regression and generalized estimating equations. PGD cases had higher levels of monocyte chemotactic protein-1 (MCP-1)/chemokine CC motif ligand 2 (CCL2) and interferon (IFN)-inducible protein (IP-10)/chemokine CXC motif ligand 10 (CXCL10) (both p < 0.05), suggesting recruitment of monocytes and effector T cells in PGD. In addition, PGD cases had lower levels of interleukin (IL-13) (p = 0.05) and higher levels of IL-2R (p = 0.05). Proinflammatory cytokines, including tumor necrosis factor (TNF)-alpha, and IFN-gamma decreased to very low levels after transplant in both PGD cases and controls, exhibiting no differences between the two groups. These findings were independent of clinical variables including diagnosis in multivariable analyses, but may be affected by cardiopulmonary bypass. Profound injury in clinical PGD is distinguished by the upregulation of selected chemokine pathways, which may useful for the prediction or early detection of PGD if confirmed in future studies.


Subject(s)
Biomarkers/blood , Chemokines/blood , Cytokines/blood , Lung Transplantation/adverse effects , Primary Graft Dysfunction/etiology , Adult , Case-Control Studies , Cohort Studies , Female , Graft Rejection , Humans , Inflammation Mediators , Male , Middle Aged , Primary Graft Dysfunction/blood , Prospective Studies , Young Adult
12.
Am J Transplant ; 7(11): 2573-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17908278

ABSTRACT

Primary graft dysfunction (PGD), a form of acute lung injury occurring within 72 h following lung transplantation, is characterized by pulmonary edema and diffuse alveolar damage. We hypothesized that higher concentrations of intercellular adhesion molecule-1 (ICAM-1) and von Willebrand factor (vWF) would be associated with the occurrence of PGD. A total of 128 lung transplant recipients among 7 lung transplant centers were enrolled in a multicenter, prospective, cohort study. Blood specimens were collected preoperatively and at 6, 24, 48 and 72 h following lung transplantation. The primary outcome was Grade 3 PGD at 72 h after transplant. Logistic regression and generalized estimating equations (GEE) were used to analyze plasma ICAM-1 and vWF. At each postoperative timepoint, mean plasma ICAM-1 concentrations were higher for patients with PGD versus no PGD. The GEE contrast estimate for the association of plasma ICAM-1 with PGD was 107.5 ng/mL (95% CI 38.7, 176.3), p = 0.002. In the multivariate analyses, this finding was independent of all clinical variables except pulmonary artery pressures prior to transplant. There was no association between plasma vWF levels and PGD. We conclude that higher levels of plasma ICAM-1 are associated with PGD following lung transplantation.


Subject(s)
Intercellular Adhesion Molecule-1/blood , Lung Transplantation/pathology , Postoperative Complications/blood , von Willebrand Factor/metabolism , Adult , Biomarkers/blood , Cohort Studies , Female , Humans , Male , Middle Aged , Regression Analysis , Reproducibility of Results
13.
Am J Transplant ; 6(10): 2436-42, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16869805

ABSTRACT

We previously reported poorer survival among non-Hispanic blacks and Hispanics with idiopathic pulmonary fibrosis (IPF) compared to non-Hispanic whites at our center. In the current study, we hypothesized that these disparities would exist in a nationwide cohort of wait-listed patients with IPF. We performed a retrospective cohort study of 2635 patients with IPF listed for lung transplantation between 1995 and 2003 at 94 transplant centers in the United States. The age-adjusted mortality rate was higher among non-Hispanic blacks [hazard ratio (HR) = 1.24, 95% confidence interval (CI) 1.06-1.45, p = 0.009] and Hispanics (HR = 1.29, 95% CI 1.06-1.56, p = 0.01) compared to non-Hispanic whites. These findings persisted after adjustment for transplantation, medical comorbidities and socioeconomic status. Worse lung function at the time of listing appeared to explain some of these differences (HR for non-Hispanic blacks after adjustment for forced vital capacity percent predicted = 1.16, 95% CI 0.98-1.36, p = 0.09; HR for Hispanics = 1.21, 95% CI 0.99-1.48, p = 0.056). In summary, black and Hispanic patients with IPF have worse survival than whites after listing for lung transplant.


Subject(s)
Ethnicity , Pulmonary Fibrosis/epidemiology , Racial Groups , Female , Follow-Up Studies , Humans , Incidence , Lung Transplantation , Male , Middle Aged , Prognosis , Pulmonary Fibrosis/surgery , Retrospective Studies , Risk Factors , Severity of Illness Index , Survival Rate/trends , United States/epidemiology
14.
Eur Respir J ; 27(3): 578-84, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16507859

ABSTRACT

Idiopathic pulmonary arterial hypertension (IPAH) is characterised by in situ thrombosis and increased thromboxane (Tx) A2 synthesis; however, there are no studies of antiplatelet therapy in IPAH. The aim of the current study was to determine the biochemical effects of aspirin (ASA) and clopidogrel on platelet function and eicosanoid metabolism in patients with IPAH. A randomised, double-blind, placebo-controlled crossover study of ASA 81 mg once daily and clopidogrel 75 mg once daily was performed. Plasma P-selectin levels and aggregometry were measured after exposure to adenosine diphosphate, arachidonic acid and collagen. Serum levels of TxB2 and urinary metabolites of TxA2 and prostaglandin I2 (Tx-M and PGI-M, respectively) were assessed. A total of 19 IPAH patients were enrolled, of whom nine were being treated with continuous intravenous epoprostenol. ASA and clopidogrel significantly reduced platelet aggregation to arachidonic acid and adenosine diphosphate, respectively. ASA significantly decreased serum TxB2, urinary Tx-M levels and the Tx-M/PGI-M ratio, whereas clopidogrel had no effect on eicosanoid levels. Neither drug significantly lowered plasma P-selectin levels. Epoprostenol use did not affect the results. In conclusion, aspirin and clopidogrel inhibited platelet aggregation, and aspirin reduced thromboxane metabolite production without affecting prostaglandin I2 metabolite synthesis. Further clinical trials of aspirin in patients with idiopathic pulmonary arterial hypertension should be performed.


Subject(s)
Aspirin/pharmacology , Aspirin/therapeutic use , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/metabolism , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation Inhibitors/therapeutic use , Platelet Aggregation/drug effects , Thromboxane A2/biosynthesis , Ticlopidine/analogs & derivatives , Adult , Clopidogrel , Cross-Over Studies , Double-Blind Method , Female , Humans , Male , Middle Aged , Ticlopidine/pharmacology , Ticlopidine/therapeutic use
15.
Am J Transplant ; 6(2): 398-403, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16426327

ABSTRACT

Minority patients have worse outcomes than nonminority patients in a variety of pulmonary diseases. We aimed to compare the survival of Black and Hispanic patients to that of others with idiopathic pulmonary fibrosis (IPF). We performed a retrospective cohort study of patients with IPF who were evaluated for lung transplantation at our center. Kaplan-Meier survival curves and Cox proportional hazards models were used to compare survival between groups. Black and Hispanic patients had spirometry, lung volumes and diffusion capacity that were similar to others, but had worse exercise capacity. Minority patients had a significantly increased risk of death compared to others independent of transplantation status (hazard ratio = 3.3, 95% CI 1.2-8.9, p = 0.02). Differences in exercise capacity, pulmonary hemodynamics and socioeconomic factors appeared to account for some of the differences in survival. Black and Hispanic patients with IPF had an increased risk of death following referral for lung transplantation. This finding may be due to differences in disease progression and/or differences in access to medical care among minority patients. Future studies should confirm our findings in a larger cohort. The elimination of racial and ethnic disparities in outcome should be a priority for clinicians and researchers in this field.


Subject(s)
Ethnicity , Lung Transplantation/mortality , Lung Transplantation/physiology , Pulmonary Fibrosis/surgery , Racial Groups , Aged , Blood Pressure , Cohort Studies , Exercise Test , Female , Humans , Male , Middle Aged , Respiratory Function Tests , Retrospective Studies , Survival Analysis
18.
Am J Cardiol ; 83(6): 984-6, A10, 1999 Mar 15.
Article in English | MEDLINE | ID: mdl-10190427

ABSTRACT

Left main coronary artery compression by the pulmonary artery may be seen in patients with pulmonary hypertension who are undergoing cardiac catheterization. Cardiac magnetic resonance imaging is useful in these patients to document extrinsic compression, which might otherwise be mistaken for intrinsic atherosclerotic disease.


Subject(s)
Coronary Disease/etiology , Coronary Vessels/pathology , Hypertension, Pulmonary/complications , Pulmonary Artery/pathology , Cineangiography , Coronary Disease/diagnosis , Coronary Disease/diagnostic imaging , Female , Humans , Hypertension, Pulmonary/pathology , Magnetic Resonance Imaging, Cine , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...